Literature DB >> 7065730

Chloroquine retinopathy: is there a safe daily dose?

J S Marks.   

Abstract

Published case reports of chloroquine retinopathy rarely include details of daily dosage, but 30 reports where this information was available included 78 patients who developed impaired visual acuity an 13 had received daily doses of 250 mg or less. Eleven cases of ocular toxicity attributed to chloroquine were reported to the Committee on Safety of Medicines but only 2 developed impaired vision on 250 mg daily. A postal questionnaire among 41 rheumatology and 33 ophthalmology centres showed 2 patients who developed impaired vision as a result of treatment with chloroquine in a daily dose not exceeding 250 mg. Serious visual impairment related to chloroquine rarely occurs if the daily dose does not exceed 250 mg.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7065730      PMCID: PMC1000864          DOI: 10.1136/ard.41.1.52

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  46 in total

1.  Ocular abnormalities in patients treated with synthetic antimalarial drugs.

Authors:  P HENKIND; N F ROTHFIELD
Journal:  N Engl J Med       Date:  1963-08-29       Impact factor: 91.245

2.  Chloroquine retinopathy. A further case.

Authors:  J B GEORGE; P C MITCHELL
Journal:  J R Army Med Corps       Date:  1962       Impact factor: 1.285

3.  Electroretinographic changes in chloroquine therapy.

Authors:  F JANSSON
Journal:  Acta Ophthalmol Suppl       Date:  1962

4.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

5.  Unusual ocular lesions in a case of systemic lupus erythematosus.

Authors:  A CAMBIAGGI
Journal:  AMA Arch Ophthalmol       Date:  1957-03

6.  Electroretinographic examinations following the application of chloroquine.

Authors:  B SCHMIDT; W MUELLER-LIMMROTH
Journal:  Acta Ophthalmol Suppl       Date:  1962

7.  Chloroquine retinopathy.

Authors:  W MAYER
Journal:  Am J Ophthalmol       Date:  1962-05       Impact factor: 5.258

8.  The prevention of drug-induced retinopathies.

Authors:  S J Crews
Journal:  Trans Ophthalmol Soc U K       Date:  1966

9.  Chloroquine retinopathy. Early detection by retinal threshold test.

Authors:  R E Carr; P Gouras; R D Gunkel
Journal:  Arch Ophthalmol       Date:  1966-02

10.  Retinal damage by light in rats.

Authors:  W K Noell; V S Walker; B S Kang; S Berman
Journal:  Invest Ophthalmol       Date:  1966-10
View more
  7 in total

1.  Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6-month comparative study.

Authors:  P D Fowler; M F Shadforth; P R Crook; A Lawton
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

2.  Screening for antimalarial maculopathy in rheumatology clinics.

Authors:  B W Fleck; A L Bell; J D Mitchell; B J Thomson; N P Hurst; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21

Review 3.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

4.  Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration?

Authors:  Samuel K Shinjo; Otacílio O Maia; Vivian A P Tizziani; Celso Morita; Jussara A L Kochen; Walter Y Takahashi; Ieda M M Laurindo
Journal:  Clin Rheumatol       Date:  2007-01-31       Impact factor: 3.650

5.  The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report.

Authors:  Eun Hee Hong; Seong Joon Ahn; Han Woong Lim; Byung Ro Lee
Journal:  BMC Ophthalmol       Date:  2017-07-12       Impact factor: 2.209

Review 6.  Potential specific therapies in COVID-19.

Authors:  Muhammad Hamdan Gul; Zin Mar Htun; Nauman Shaukat; Muhammad Imran; Ahmad Khan
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

7.  Macular edema might be a rare presentation of hydroxychloroquine-induced retinal toxicity.

Authors:  Chih-Yao Chang; Shwu-Jiuan Sheu
Journal:  Taiwan J Ophthalmol       Date:  2017 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.